<SEC-DOCUMENT>0001104659-22-086282-index.html : 20220804 <SEC-HEADER>0001104659-22-086282.hdr.sgml : 20220804 <ACCEPTANCE-DATETIME>20220804182425 ACCESSION NUMBER: 0001104659-22-086282 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220802 FILED AS OF DATE: 20220804 DATE AS OF CHANGE: 20220804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BURGESS DANIEL D CENTRAL INDEX KEY: 0001239650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 221138109 MAIL ADDRESS: STREET 1: C/O HOLLIS-EDEN PHARMACEUTICALS STREET 2: 4435 EASTGATE MALL STE.400 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25-28 NORTH WALL QUAY CITY: DUBLIN STATE: L2 ZIP: D01 H104 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 414 COMMERCE DRIVE STREET 2: STE 120 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>tm2222534-13_4seq1.xml <DESCRIPTION>OWNERSHIP DOCUMENT <TEXT> Document 1 - file: tm2222534-13_4seq1.html
Document 1 - RAW XML: tm2222534-13_4seq1.xml
</DOCUMENT> </SEC-DOCUMENT>